Skip to content
10-Q

Quarterly Report

Vera Therapeutics, Inc. VERA

0001193125-25-266881

← back to feed
Filed
Nov 5, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Oct 30, 2025 63.93M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.85M sh
Shares Diluted Q3 2025 · Sep 30, 2025 63.77M sh
Shares Diluted Q3 2025 · Sep 30, 2024 54.9M sh
Shares Diluted Q3 2025 · Sep 30, 2024 53.54M sh
Stock Repurchased Q3 2025 · Sep 30, 2025 $0
Stock Repurchased Q3 2025 · Sep 30, 2024 $13K
Capex Q3 2025 · Sep 30, 2025 $528K
Capex Q3 2025 · Sep 30, 2024 $327K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$171.11M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$95.5M
Long Term Debt Q3 2025 · Sep 30, 2025 $74.65M
Long Term Debt Q3 2025 · Dec 31, 2024 $50.69M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $57.77M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $92.65M
Stockholders Equity Q3 2025 · Sep 30, 2025 $398.88M
Stockholders Equity Q3 2025 · Jun 30, 2025 $468.28M
Stockholders Equity Q3 2025 · Mar 31, 2025 $535M
Stockholders Equity Q3 2025 · Dec 31, 2024 $577.16M
Stockholders Equity Q3 2025 · Sep 30, 2024 $289.06M
Stockholders Equity Q3 2025 · Jun 30, 2024 $327.87M
Stockholders Equity Q3 2025 · Mar 31, 2024 $353.54M
Stockholders Equity Q3 2025 · Dec 31, 2023 $101.69M
Current Liabilities Q3 2025 · Sep 30, 2025 $41.88M
Current Liabilities Q3 2025 · Dec 31, 2024 $25.37M
Total Liabilities Q3 2025 · Sep 30, 2025 $118.62M
Total Liabilities Q3 2025 · Dec 31, 2024 $78.53M
Current Assets Q3 2025 · Sep 30, 2025 $511.31M
Current Assets Q3 2025 · Dec 31, 2024 $651.22M
Total Assets Q3 2025 · Sep 30, 2025 $517.5M
Total Assets Q3 2025 · Dec 31, 2024 $655.68M
Eps Diluted Q3 2025 · Sep 30, 2025 −$1.26
Eps Diluted Q3 2025 · Sep 30, 2025 −$3.27
Eps Diluted Q3 2025 · Sep 30, 2024 −$0.85
Eps Diluted Q3 2025 · Sep 30, 2024 −$2.03
Eps Basic Q3 2025 · Sep 30, 2025 −$1.26
Eps Basic Q3 2025 · Sep 30, 2025 −$3.27
Eps Basic Q3 2025 · Sep 30, 2024 −$0.85
Eps Basic Q3 2025 · Sep 30, 2024 −$2.03
Sga Expense Q3 2025 · Sep 30, 2025 $27.46M
Sga Expense Q3 2025 · Sep 30, 2025 $65.32M
Sga Expense Q3 2025 · Sep 30, 2024 $9.49M
Sga Expense Q3 2025 · Sep 30, 2024 $25.43M
Rd Expense Q3 2025 · Sep 30, 2025 $56.47M
Rd Expense Q3 2025 · Sep 30, 2025 $155.95M
Rd Expense Q3 2025 · Sep 30, 2024 $40.31M
Rd Expense Q3 2025 · Sep 30, 2024 $92.83M
Net Income Q3 2025 · Sep 30, 2025 −$80.29M
Net Income Q3 2025 · Sep 30, 2025 −$208.52M
Net Income Q3 2025 · Jun 30, 2025 −$76.53M
Net Income Q3 2025 · Mar 31, 2025 −$51.69M
Net Income Q3 2025 · Sep 30, 2024 −$46.63M
Net Income Q3 2025 · Sep 30, 2024 −$108.72M
Net Income Q3 2025 · Jun 30, 2024 −$33.71M
Net Income Q3 2025 · Mar 31, 2024 −$28.38M
Operating Income Q3 2025 · Sep 30, 2025 −$83.93M
Operating Income Q3 2025 · Sep 30, 2025 −$221.27M
Operating Income Q3 2025 · Sep 30, 2024 −$49.8M
Operating Income Q3 2025 · Sep 30, 2024 −$118.26M